Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-209x
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-209x
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-131x
60%
—
—
Never
—
5 Years
Score—
Net Growth-131x
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Acurx Pharmaceuticals LLC fundamental performance
Across Acurx Pharmaceuticals LLC's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 12M to -$ 7M. Revenue increased in 0% of the years measured; net income in 60%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.54 | — |
1 Year2025-08-12 | $ 4.43 | -65.28% |
5 Years2021-08-12 | $ 96.00 | -98.40% |
All Time2021-06-25 | $ 157.80 | -99.02% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-06-25 |
|---|---|---|---|---|
| Price | $ 1.54 | $ 4.43 | $ 96.00 | $ 157.80 |
| Return | — | -65.28% | -98.40% | -99.02% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 1.68B | $ 9.25B |
| 2025 | $ 0.00 | -$ 7M | $ 7.55B |
| 2024 | $ 0.00 | -$ 14M | $ 3M |
| 2023 | $ 0.00 | -$ 14M | $ 7M |
| 2022 | $ 0.00 | -$ 12M | $ 9M |
| IPO2021 | $ 0.00 | -$ 12M | $ 12M |
Explore beyond ACXP
You're looking at Acurx Pharmaceuticals LLC. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
